{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:51:51Z","timestamp":1787849511164,"version":"build-2784847793"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.eplepsyres.2021.106675","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T12:13:29Z","timestamp":1621426409000},"page":"106675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications"],"prefix":"10.1016","volume":"174","author":[{"given":"Shreshta","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidrun","family":"Potschka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Prarthana","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjari","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1852-9191","authenticated-orcid":false,"given":"Divya","family":"Vohora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2021.106675_bib0005","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1212\/CON.0000000000000715","article-title":"Update on antiepileptic drugs 2019","volume":"25","author":"Abou-Khalil","year":"2019","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101615","article-title":"Remdesivir as a possible therapeutic option for the COVID-19","author":"Al-Tawfiq","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.onehlt.2020.100128","article-title":"Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses","volume":"9","author":"Amirian","year":"2020","journal-title":"One Health"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0020","series-title":"Interactions with Experimental COVID-19 Therapies","author":"Anon","year":"2021"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0025","series-title":"National Health Commission and State Administration of Traditional Chinese Medicine","author":"Anon","year":"2021"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.seizure.2020.05.005","article-title":"Seizures associated with coronavirus infections","volume":"79","author":"Asadi-Pooya","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116832","article-title":"Central nervous system manifestations of COVID-19: a systematic review","volume":"413","author":"Asadi-Pooya","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cellimm.2009.03.007","article-title":"Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells","volume":"258","author":"Bancos","year":"2009","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","article-title":"A screen of FDA-approved drugs for inhibitors of zika virus infection","volume":"20","author":"Barrows","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0050","first-page":"245","article-title":"Seizures and cancer: drug interactions of anticonvulsants with chemotherapeutic agents, tyrosine kinase inhibitors and glucocorticoids","volume":"3","author":"B\u00e9nit","year":"2015","journal-title":"Neurooncol. Pract."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0055","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1111\/epi.14557","article-title":"Progress report on new antiepileptic drugs: a summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development","volume":"59","author":"Bialer","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/DDDT.S150580","article-title":"Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection","volume":"13","author":"Biggioggero","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1528-1167.2011.03335.x","article-title":"Antiepileptic drug selection for people with HIV\/AIDS: evidence-based guidelines from the ILAE and AAN","volume":"53","author":"Birbeck","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0070","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bcp.2010.04.034","article-title":"Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels","volume":"80","author":"Bock","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0075","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/jmv.26111","article-title":"Tocilizumab challenge: a series of cytokine storm therapy experiences in hospitalized COVID-19 pneumonia patients","volume":"92","author":"Borku Uysal","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104805","article-title":"Ivermectin and COVID-19: a report in antiviral research, widespread interest, an FDA warning, two letters to the editor and the authors\u2019 responses","volume":"178","author":"Bray","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0085","series-title":"Pharmacology of Chloroquine and Hydroxychloroquine, Hydroxychloroquine and Chloroquine Retinopathy","first-page":"35","author":"Browning","year":"2014"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0090","first-page":"14","article-title":"Carbamazepine toxicity after starting combination antiretroviral therapy including ritonavir and efavirenz","author":"Burman","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.eng.2020.03.007","article-title":"Experimental treatment with favipiravir for COVID-19: an open-label control study","author":"Cai","year":"2020","journal-title":"Engineering"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy","author":"Cao","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0110","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0115","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00228-019-02691-4","article-title":"Interaction between paracetamol and lamotrigine: new insights from the FDA Adverse Event Reporting System (FAERS) database","volume":"75","author":"Carnovale","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.33588\/rn.7009.2020179","article-title":"Neurological complications of coronavirus and COVID-19","volume":"70","author":"Carod-Artal","year":"2020","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0125","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4269\/ajtmh.20-0271","article-title":"Ivermectin and COVID-19: keeping rigor in times of urgency","volume":"102","author":"Chaccour","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/jnnp.47.10.1087","article-title":"Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients","volume":"47","author":"Chalk","year":"1984","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0135","series-title":"Favipiravir Versus Arbidol for COVID-19: A Randomized Clinical Trial","author":"Chen","year":"2020"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0140","article-title":"A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19)","volume":"49","author":"Chen","year":"2020","journal-title":"J. Zhejiang Univ. (Med. Sci.)"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0145","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0888-2","article-title":"The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin","author":"Chorin","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0155","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.200334","article-title":"The rheumatologist\u2019s role in COVID-19","author":"Cron","year":"2020","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2183\/pjab.87.13","article-title":"Ivermectin,\u2019 wonder drug\u2019 from Japan: the human use perspective","volume":"87","author":"Crump","year":"2011","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0165","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00007691-199606000-00011","article-title":"Displacement of valproic acid and carbamazepine from protein binding in normal and uremic sera by tolmetin, ibuprofen, and naproxen: presence of inhibitor in uremic serum that blocks valproic acid-naproxen interactions","volume":"18","author":"Dasgupta","year":"1996","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pediatrneurol.2018.04.009","article-title":"Hypothesis: presymptomatic treatment of Sturge-Weber syndrome with aspirin and antiepileptic drugs may delay seizure onset","volume":"90","author":"Day","year":"2019","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0175","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1128\/AAC.48.11.4328-4331.2004","article-title":"Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults","volume":"48","author":"DiCenzo","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0180","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/epi4.12317","article-title":"Therapeutic effect of Anakinra in the relapsing chronic phase of febrile infection-related epilepsy syndrome","volume":"4","author":"Dilena","year":"2019","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/cpt.1844","article-title":"Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection","volume":"108","author":"Du","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0190","first-page":"178","article-title":"Seizures following chloroquine treatment of type II lepra reaction: a case report","volume":"69","author":"Ebenso","year":"1998","journal-title":"Lepr. Rev."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0195","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13148-020-00912-7","article-title":"Management of epigenomic networks entailed in coronavirus infections and COVID-19","volume":"12","author":"El Baba","year":"2020","journal-title":"Clin. Epigenetics"},{"issue":"559","key":"10.1016\/j.eplepsyres.2021.106675_bib0200","first-page":"e515","article-title":"Anti-retroviral therapy-induced status epilepticus in \u201cpseudo-HIV serodeconversion\u201d","volume":"32","author":"Etgen","year":"2010","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0205","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0210","series-title":"FDA Advises Patients on Use of Non-steroidal Anti-inflammatory Drugs (NSAIDs) for COVID-19","first-page":"2020","author":"FDA","year":"2020"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0215","series-title":"Dexamethasone","author":"Ferner","year":"2020"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0220","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0049-0172(10)80012-5","article-title":"Mechanism of action of hydroxychloroquine as an antirheumatic drug","volume":"23","author":"Fox","year":"1993","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0225","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-2125.1983.tb01540.x","article-title":"Chloroquine intoxication","volume":"15","author":"Frisk-Holmberg","year":"1983","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0230","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc. Jpn. Acad. Ser B"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0235","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.joca.2013.06.026","article-title":"The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial","volume":"21","author":"Gallelli","year":"2013","journal-title":"Osteoarthritis Cartil."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0240","doi-asserted-by":"crossref","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","author":"Gao","year":"2020","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0245","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/bcp.12840","article-title":"Paracetamol decreases steady\u2010state exposure to lamotrigine by induction of glucuronidation in healthy subjects","volume":"81","author":"Gastrup","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0255","article-title":"Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)","author":"Giollo","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0260","first-page":"1","article-title":"Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import","volume":"6","author":"G\u00f6tz","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0265","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1365-2125.2009.03545.x","article-title":"Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4-dimethyl-benziso-(2H)-selenazine (ALT-2074), an experimental catalytic mimic of glutathione oxidase","volume":"68","author":"Greenblatt","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0270","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","author":"Grein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0275","first-page":"52","article-title":"Probable phenytoin-dexamethasone interaction: a case report of subtherapeutic phenytoin concentrations","author":"Griffiths","year":"2018","journal-title":"Can. J. Hosp. Pharm."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0285","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","author":"Holshue","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0290","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0295","series-title":"FAQs About COVID-19 and Epilepsy for Clinicians in English","author":"ILAE","year":"2020"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0300","series-title":"Case Report a Case of COVID-19 Pneumonia That Did Not Worsen and Was Relieved by Early Administration of Favipiravir and Ciclesonide","author":"Ito","year":"2021"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0305","series-title":"AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II\/III Multicenter Randomized Clinical Trial","author":"Ivashchenko","year":"2020"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0310","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s10067-017-3579-8","article-title":"Antimalarial myopathy in a systemic lupus erythematosus patient with quadriparesis and seizures: a case-based review","volume":"36","author":"Jafri","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0315","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/157015910792246254","article-title":"Antiepileptic drug interactions - principles and clinical implications","volume":"8","author":"Johannessen","year":"2010","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0320","article-title":"A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19)","volume":"12","author":"Kakodkar","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0325","doi-asserted-by":"crossref","first-page":"877","DOI":"10.7326\/0003-4819-91-6-877","article-title":"Ibuprofen","volume":"91","author":"Kantor","year":"1979","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237903","article-title":"A systematic review of trial registry entries for randomized clinical trials investigating COVID-19 medical prevention and treatment","volume":"15","author":"Karlsen","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0335","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/ana.24806","article-title":"Febrile infection-related epilepsy syndrome treated with anakinra","volume":"80","author":"Kenney-Jung","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0340","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s00296-012-2423-3","article-title":"Interleukin-6 and cytochrome-P450, reason for concern?","volume":"32","author":"Kim","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0345","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5114\/ada.2018.77675","article-title":"Seizures as a rare adverse effect of chloroquine therapy in systemic lupus erythematosus patients: a case report and literature survey","volume":"35","author":"Krzeminski","year":"2018","journal-title":"Postepy Dermatol. Alergol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0350","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A novel coronavirus associated with severe acute respiratory syndrome","volume":"348","author":"Ksiazek","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0355","series-title":"First 12 Patients with Coronavirus Disease 2019 (COVID-19) in the United States","author":"Kujawski","year":"2020"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0360","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41419-020-2721-8","article-title":"Is hydroxychloroquine beneficial for COVID-19 patients?","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0365","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jmv.25728","article-title":"The neuroinvasive potential of SARS\u2010CoV2 may play a role in the respiratory failure of COVID\u201019 patients","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0370","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002960000066","article-title":"Hydroxychloroquine-induced seizure in a patient with systemic lupus erythematosus","volume":"20","author":"Malcangi","year":"2000","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007966","article-title":"Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: a randomized proof-of-concept clinical trial","volume":"14","author":"Mandro","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0380","first-page":"415","article-title":"Hydroxychloroquine\/ chloroquine as a treatment choice or prophylaxis for Covid-19 at the primary care level in developing countries: a Primum non Nocere dilemma","author":"Medina","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0385","first-page":"1061","article-title":"Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs","volume":"11","author":"Moore","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0390","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40264-020-00953-0","article-title":"Does Ibuprofen Worsen COVID-19?","volume":"43","author":"Moore","year":"2020","journal-title":"Drug Saf."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0395","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01896-0","article-title":"Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports","volume":"17","author":"Najjar","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0400","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00003088-199018010-00003","article-title":"Pharmacokinetic drug interactions with phenytoin (Part I)","volume":"18","author":"Nation","year":"1990","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0405","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00618515","article-title":"Antipyretic analgesics in patients on antiepileptic drug therapy","volume":"15","author":"Neuvonen","year":"1979","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0410","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30314-3","article-title":"Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?","author":"Nicolau","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0415","series-title":"Metabolic Disturbances and Inflammatory Dysfunction Predict Severity of Coronavirus Disease 2019 (COVID-19): A Retrospective Study","author":"Nie","year":"2020"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0420","series-title":"COVID-19 Treatment Guidelines","author":"NIH","year":"2020"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0425","article-title":"Two cases of COVID-19 pneumonia including use of favipiravir","author":"Noda","year":"2020","journal-title":"Jpn. Assoc. Infect. Dis."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0430","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jtbi.2008.07.030","article-title":"Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors","volume":"254","author":"Nukoolkarn","year":"2008","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0435","first-page":"301","article-title":"Modified elimination of prednisolone in epileptic patients on carbamazepine monotherapy, and in women using low-dose oral contraceptives","volume":"40","author":"Olivesi","year":"1986","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0440","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pt.2014.07.005","article-title":"Ivermectin: panacea for resource-poor communities?","volume":"30","author":"Omura","year":"2014","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0445","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-020-4797-2","article-title":"Cryptococcal meningitis and immune reconstitution inflammatory syndrome in a pediatric patient with HIV after switching to second line antiretroviral therapy: a case report","volume":"20","author":"Otto","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0450","series-title":"A Systematic Review to Assess Seizure Risk with Chloroquine Therapy in Persons with Epilepsy","author":"Pati","year":"2020"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0455","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/FTD.0000000000000546","article-title":"Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update","volume":"40","author":"Patsalos","year":"2018","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0460","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","article-title":"Clinically relevant drug interactions with antiepileptic drugs","volume":"61","author":"Perucca","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0465","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S2055-6640(20)30016-9","article-title":"A review of the safety of favipiravir - a potential treatment in the COVID-19 pandemic?","volume":"6","author":"Pilkington","year":"2020","journal-title":"J. Virus Erad."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0470","series-title":"Pharmaceuticals and Medical Devices Agency: Avigan (favipiravir). Review Report","author":"PMDA","year":"2014"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0475","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1528-1167.2010.02585.x","article-title":"Modulating P-glycoprotein regulation: Future perspectives for pharmacoresistant epilepsies?","volume":"51","author":"Potschka","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0480","series-title":"Inhaled Ibuprofen to Treat COVID-19","author":"Qu\u00edmica Luar","year":"2021"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0485","series-title":"ICON (Ivermectin in COvid Nineteen) study: Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID19","author":"Rajter","year":"2020"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0490","series-title":"Clinical Virology","author":"Richman","year":"2016"},{"issue":"1259","key":"10.1016\/j.eplepsyres.2021.106675_bib0495","first-page":"e1255","article-title":"Ibuprofen use and clinical outcomes in COVID-19 patients","volume":"26","author":"Rinott","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0500","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrrheum.2017.83","article-title":"The role of IL-6 in host defence against infections: immunobiology and clinical implications","volume":"13","author":"Rose-John","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","author":"Rothan","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0510","series-title":"Clinically Relevant drug-Drug Interaction Between AEDs and Medications Used in the Treatment of COVID-19 Patients","author":"Russo","year":"2020"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0515","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ejpn.2019.08.001","article-title":"Centromedian thalamic nuclei deep brain stimulation and Anakinra treatment for FIRES \u2013 two different outcomes","volume":"23","author":"Sa","year":"2019","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0520","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.6019","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review","author":"Sanders","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0525","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today\u2019s diseases","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0530","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2310\/7060.2000.00048","article-title":"Seizures after antimalarial medication in previously healthy persons","volume":"7","author":"Schiemann","year":"2000","journal-title":"J. Travel Med."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0535","first-page":"1","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","author":"Schrezenmeier","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0540","first-page":"9","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0545","series-title":"Immunopathological Characteristics of Coronavirus Disease 2019 Cases in Guangzhou, China","author":"Shi","year":"2020"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0550","article-title":"Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo [2, 1-f][triazin-4-amino] adenine C-Nucleoside (GS-5734) for the treatment of ebola and emerging viruses","author":"Siegel","year":"2017","journal-title":"ACS Publ."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0555","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.dsx.2020.06.054","article-title":"Role of corticosteroid in the management of COVID-19: a systemic review and a Clinician\u2019s perspective","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0560","article-title":"Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0565","first-page":"475","article-title":"Aspirin modulates the anticonvulsant effect of diazepam and sodium valproate in pentylenetetrazole and maximal electroshock induced seizures in mice","volume":"45","author":"Srivastava","year":"2001","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0570","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1210\/jcem-41-5-887","article-title":"Effects of Diphenylhydantoin, phenobarbital, and diazepam on the metabolism of methylprednisolone and its sodium succinate","volume":"41","author":"Stjernholm","year":"1975","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0575","series-title":"Drug Interaction Concerns for COVID-19 Treatments","author":"Streetman","year":"2020"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0580","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1358\/mf.2003.25.8.778080","article-title":"Evaluation of antiepileptic activity of aspirin in combination with newer antiepileptic lamotrigine in mice","volume":"25","author":"Tandon","year":"2003","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0585","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00296-003-0435-8","article-title":"Seizure associated with chloroquine therapy in a patient with systemic lupus erythematosus","volume":"24","author":"Tristano","year":"2004","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0590","first-page":"21","article-title":"A review of SARS-CoV-2 and the ongoing clinical trials","author":"Tu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0595","series-title":"Role of Ibuprofen and Other Medicines on Severity of Coronavirus Disease","first-page":"2019","author":"University Hospital","year":"2020"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0600","doi-asserted-by":"crossref","DOI":"10.1007\/s12471-020-01429-7","article-title":"Chloroquine-induced QTc prolongation in COVID-19 patients","author":"van den Broek","year":"2020","journal-title":"Netherlands Heart J."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0605","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clpt.2006.04.014","article-title":"Lopinavir\/ritonavir reduces lamotrigine plasma concentrations in healthy subjects","volume":"80","author":"van der Lee","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0610","series-title":"Favipiravir Approved As Anti- COVID-19 Drug; DCGI Approves Influenza Treatment Drug for Covid-19 Treatment in India","author":"Varadharajan","year":"2020"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0615","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0620","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1042\/BJ20120150","article-title":"Ivermectin is a specific inhibitor of importin \u03b1\/\u03b2-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus","volume":"443","author":"Wagstaff","year":"2012","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.eplepsyres.2021.106675_bib0625","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/ID9.0000000000000002","article-title":"Diagnosis and treatment protocol for COVID-19 patients (Tentative 8th Edition)","volume":"1","author":"Wang","year":"2021","journal-title":"Infect. Dis. Immun."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0630","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0635","article-title":"Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China","author":"Wang","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0640","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0645","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/rheumatology\/kez304","article-title":"Important drug interactions exist between cannabidiol oil and commonly prescribed drugs in rheumatology practice","volume":"59","author":"Wilson-Morkeh","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0650","first-page":"V1","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"202003","author":"Xu","year":"2020","journal-title":"ChinaXiv"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0655","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0660","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.lfs.2011.02.017","article-title":"Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety","volume":"88","author":"Yamaori","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0665","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.cmi.2020.06.020","article-title":"Corticosteroid administration for viral pneumonia: COVID-19 and beyond","volume":"26","author":"Yang","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104760","article-title":"The broad spectrum antiviral ivermectin targets the host nuclear transport importin \u03b1\/\u03b21 heterodimer","author":"Yang","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0675","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25729","article-title":"A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus\u2014a possible reference for coronavirus disease\u201019 treatment option","author":"Yao","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0680","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0685","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.qai.0000219774.20174.64","article-title":"Lopinavir\/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers","volume":"42","author":"Yeh","year":"2006","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0690","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25888","article-title":"Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019","author":"Yin","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0695","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1684\/epd.2014.0714","article-title":"Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs","volume":"16","author":"Zaccara","year":"2014","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0700","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0705","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/004982598239597","article-title":"Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomes","volume":"28","author":"Zeng","year":"1998","journal-title":"Xenobiotica"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0710","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/138920008784220664","article-title":"Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4","volume":"9","author":"Zhou","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0715","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2021.106675_bib0720","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1080\/01616412.2017.1326657","article-title":"Aspirin attenuates spontaneous recurrent seizures in the chronically epileptic mice","volume":"39","author":"Zhu","year":"2017","journal-title":"Neurol. Res."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121121001285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121121001285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:46:38Z","timestamp":1760276798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121121001285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":144,"alternative-id":["S0920121121001285"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106675","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106675"}}